BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
 | 
Feb 01, 2010
 |  BC Week In Review  |  Clinical News  |  Clinical Status

BNC105: Phase II started

Bionomics began a U.S. Phase II trial to evaluate intravenous BNC105 in combination with or following progression on oral Afinitor everolimus in 152...

Read the full 102 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >